Sántha Petra, Lenggenhager Daniela, Finstadsveen Anette, Dorg Linda, Tøndel Kristin, Amrutkar Manoj, Gladhaug Ivar P, Verbeke Caroline
Department of Pathology, Oslo University Hospital, Rikshospitalet, 0424 Oslo, Norway.
Department of Pathology and Molecular Pathology, University Hospital Zürich, University of Zürich, 8091 Zürich, Switzerland.
Cancers (Basel). 2021 Feb 20;13(4):895. doi: 10.3390/cancers13040895.
Inter- and intratumor heterogeneity is an important cause of treatment failure. In human pancreatic cancer (PC), heterogeneity has been investigated almost exclusively at the genomic and transcriptional level. Morphological heterogeneity, though prominent and potentially easily assessable in clinical practice, remains unexplored. This proof-of-concept study aims at demonstrating that morphological heterogeneity reflects structural and functional divergence. From the wide morphological spectrum of conventional PC, four common and distinctive patterns were investigated in 233 foci from 39 surgical specimens. Twenty-six features involved in key biological processes in PC were analyzed (immuno-)histochemically and morphometrically: cancer cell proliferation (Ki67) and migration (collagen fiber alignment, MMP14), cancer stem cells (CD44, CD133, ALDH1), amount, composition and spatial arrangement of extracellular matrix (epithelial proximity, total collagen, collagen I and III, fibronectin, hyaluronan), cancer-associated fibroblasts (density, αSMA), and cancer-stroma interactions (integrins α2, α5, α1; caveolin-1). All features differed significantly between at least two of the patterns. Stromal and cancer-cell-related features co-varied with morphology and allowed prediction of the morphological pattern. In conclusion, morphological heterogeneity in the cancer-cell and stromal compartments of PC correlates with structural and functional diversity. As such, histopathology has the potential to inform on the operationality of key biological processes in individual tumors.
肿瘤间和肿瘤内的异质性是治疗失败的重要原因。在人类胰腺癌(PC)中,几乎仅在基因组和转录水平上研究了异质性。形态学异质性虽然在临床实践中很突出且可能易于评估,但仍未得到探索。这项概念验证研究旨在证明形态学异质性反映了结构和功能差异。从传统PC的广泛形态学谱中,在来自39个手术标本的233个病灶中研究了四种常见且独特的模式。对PC中关键生物学过程涉及的26个特征进行了(免疫)组织化学和形态计量学分析:癌细胞增殖(Ki67)和迁移(胶原纤维排列、MMP14)、癌症干细胞(CD44、CD133、ALDH1)、细胞外基质的数量、组成和空间排列(上皮接近度、总胶原、I型和III型胶原、纤连蛋白、透明质酸)、癌症相关成纤维细胞(密度、αSMA)以及癌症-基质相互作用(整合素α2、α5、α1;小窝蛋白-1)。所有特征在至少两种模式之间存在显著差异。基质和癌细胞相关特征与形态学共同变化,并可预测形态学模式。总之,PC癌细胞和基质区室中的形态学异质性与结构和功能多样性相关。因此,组织病理学有可能为个体肿瘤中关键生物学过程的可操作性提供信息。